{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:25:01Z","timestamp":1790648701218,"version":"4.1.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-108792GB-I00"],"award-info":[{"award-number":["PID2019-108792GB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-137963OB-I00"],"award-info":[{"award-number":["PID2022-137963OB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["202012-32"],"award-info":[{"award-number":["202012-32"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Parkinson\u2019s disease (PD) is a progressive, incurable neurodegenerative disorder characterized by the loss of neuromelanin (NM)-containing dopamine neurons (DAn) in the\n                    <jats:italic>substantia nigra<\/jats:italic>\n                    of the midbrain. Non-neuronal cells are increasingly recognized as contributors to PD. We generated human microglia-like cells (hMG) from induced pluripotent stem cells (iPSC) derived from patients with LRRK2 PD-causing mutations, gene-corrected isogenic controls, and healthy donors. While neither genotype induced neurodegeneration in healthy DAn, LRRK2 hMG become hyperreactive to LPS stimulation, exhibiting increased cytokine expression, reactive oxygen species, and phagocytosis. When exposed to NM-containing particles, but not \u03b1-synuclein fibrils, LRRK2 hMG trigger DAn degeneration, in a process that is prevented by pre-treatment with the immunomodulatory drug ivermectin. Finally, post-mortem analysis of midbrain tissue of LRRK2-PD patients show increased microglia activation around NM-containing neurons, confirming our in vitro findings. Overall, our work highlights NM-activated microglia\u2019s role in PD progression, and provides a model for testing therapeutic targets.\n                  <\/jats:p>","DOI":"10.1038\/s42003-025-08544-4","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T16:54:34Z","timestamp":1755017674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson\u2019s disease model"],"prefix":"10.1038","volume":"8","author":[{"given":"Lucas","family":"Blasco-Agell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-2963","authenticated-orcid":false,"given":"Meritxell","family":"Pons-Espinal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9041-7325","authenticated-orcid":false,"given":"Veronica","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9045-0579","authenticated-orcid":false,"given":"Gerard","family":"Roch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6877-4833","authenticated-orcid":false,"given":"Jara","family":"Montero-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8195-3510","authenticated-orcid":false,"given":"Irene","family":"Fernandez-Carasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Baruffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5627-847X","authenticated-orcid":false,"given":"Marta","family":"Gonzalez-Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Richaud-Patin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senda","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7376-7470","authenticated-orcid":false,"given":"Thais","family":"Cuadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana M.","family":"Cladera-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5447-5122","authenticated-orcid":false,"given":"Joan","family":"Compte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Manglano-Artu\u00f1edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9652-6351","authenticated-orcid":false,"given":"Salvador","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3064-1648","authenticated-orcid":false,"given":"Manel","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Tolosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-9775","authenticated-orcid":false,"given":"Angel","family":"Raya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1352-989X","authenticated-orcid":false,"given":"Miquel","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3988-6254","authenticated-orcid":false,"given":"Antonella","family":"Consiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"8544_CR1","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson, D. W. Neuropathology of Parkinson disease. Parkinsonism Relat. Disord. 46, S30\u2013S33 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"8544_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey, M. G. et al. Inflammation and immune dysfunction in Parkinson disease. Nat. Rev. Immunol. 22, 657\u2013673 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"8544_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY-Y Pang","year":"2019","unstructured":"Pang, S. Y.-Y. et al. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl. Neurodegener. 8, 23 (2019).","journal-title":"Transl. Neurodegener."},{"key":"8544_CR4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/mds.28416","volume":"36","author":"V Skrahina","year":"2021","unstructured":"Skrahina, V. et al. The Rostock International Parkinson\u2019s Disease (ROPAD) study: protocol and initial findings. Mov. Disord. 36, 1005\u20131010 (2021).","journal-title":"Mov. Disord."},{"key":"8544_CR5","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1111\/febs.13305","volume":"282","author":"R Wallings","year":"2015","unstructured":"Wallings, R., Manzoni, C. & Bandopadhyay, R. Cellular processes associated with LRRK2 function and dysfunction. FEBS J. 282, 2806\u20132826 (2015).","journal-title":"FEBS J."},{"key":"8544_CR6","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.4049\/jimmunol.1000548","volume":"185","author":"A Gardet","year":"2010","unstructured":"Gardet, A. et al. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J. Immunol. 185, 5577\u20135585 (2010).","journal-title":"J. Immunol."},{"key":"8544_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00702-011-0653-2","volume":"118","author":"M Hakimi","year":"2011","unstructured":"Hakimi, M. et al. Parkinson\u2019s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. J. Neural Transm. 118, 795\u2013808 (2011).","journal-title":"J. Neural Transm."},{"key":"8544_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-017-0010-8","volume":"3","author":"DA Cook","year":"2017","unstructured":"Cook, D. A. et al. LRRK2 levels in immune cells are increased in Parkinson\u2019s disease. npj Parkinsons Dis. 3, 11 (2017).","journal-title":"npj Parkinsons Dis."},{"key":"8544_CR9","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1093\/brain\/awy077","volume":"141","author":"E Kozina","year":"2018","unstructured":"Kozina, E. et al. Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo. Brain 141, 1753\u20131769 (2018).","journal-title":"Brain"},{"key":"8544_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1523\/JNEUROSCI.5601-11.2012","volume":"32","author":"MS Moehle","year":"2012","unstructured":"Moehle, M. S. et al. LRRK2 inhibition attenuates microglial inflammatory responses. J. Neurosci. 32, 1602\u20131611 (2012).","journal-title":"J. Neurosci."},{"key":"8544_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","volume":"208","author":"F Gillardon","year":"2012","unstructured":"Gillardon, F., Schmid, R. & Draheim, H. Parkinson\u2019s disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity. Neuroscience 208, 41\u201348 (2012).","journal-title":"Neuroscience"},{"key":"8544_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-9-261","volume":"9","author":"DF Marker","year":"2012","unstructured":"Marker, D. F. et al. LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein. J. Neuroinflammation 9, 752 (2012).","journal-title":"J. Neuroinflammation"},{"key":"8544_CR13","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.stemcr.2020.04.001","volume":"14","author":"H Lee","year":"2020","unstructured":"Lee, H. et al. LRRK2 is recruited to phagosomes and co-recruits RAB8 and RAB10 in human pluripotent stem cell-derived macrophages. Stem Cell Rep. 14, 940\u2013955 (2020).","journal-title":"Stem Cell Rep."},{"key":"8544_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18755-4","volume":"11","author":"V Panagiotakopoulou","year":"2020","unstructured":"Panagiotakopoulou, V. et al. Interferon-\u03b3 signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells. Nat. Commun. 11, 5163 (2020).","journal-title":"Nat. Commun."},{"key":"8544_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-0404.1989.tb01778.x","volume":"126","author":"EC Hirsch","year":"1989","unstructured":"Hirsch, E. C., Graybiel, A. M. & Agid, Y. Selective vulnerability of pigmented dopaminergic neurons in Parkinson\u2019s disease. Acta Neurol. Scand. Suppl. 126, 19\u201322 (1989).","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"8544_CR16","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","volume":"59","author":"A Kastner","year":"1992","unstructured":"Kastner, A. et al. Is the vulnerability of neurons in the substantia nigra of patients with Parkinson\u2019s disease related to their neuromelanin content?. J. Neurochem 59, 1080\u20131089 (1992).","journal-title":"J. Neurochem"},{"key":"8544_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12640-013-9435-y","volume":"25","author":"FA Zucca","year":"2014","unstructured":"Zucca, F. A. et al. Neuromelanin of the human substantia nigra: an update. Neurotox. Res. 25, 13\u201323 (2014).","journal-title":"Neurotox. Res."},{"key":"8544_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08858-y","volume":"10","author":"I Carballo-Carbajal","year":"2019","unstructured":"Carballo-Carbajal, I. et al. Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis. Nat. Commun. 10, 973 (2019).","journal-title":"Nat. Commun."},{"key":"8544_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/brain\/awac445","volume":"146","author":"M Gonzalez-Sepulveda","year":"2023","unstructured":"Gonzalez-Sepulveda, M. et al. In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson\u2019s disease. Brain 146, 1040\u20131052 (2023).","journal-title":"Brain"},{"key":"8544_CR20","doi-asserted-by":"publisher","first-page":"5000","DOI":"10.1093\/brain\/awad331","volume":"146","author":"J Chocarro","year":"2023","unstructured":"Chocarro, J. et al. Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates. Brain 146, 5000\u20135014 (2023).","journal-title":"Brain"},{"key":"8544_CR21","doi-asserted-by":"crossref","unstructured":"Tejchman-Skrzyszewska, A. et al. Synthetic neuromelanin as a trigger of inflammation in the brain \u2013 new mouse model of Parkinson\u2019s disease. http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2023.04.28.538536 (2023).","DOI":"10.1101\/2023.04.28.538536"},{"key":"8544_CR22","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.stemcr.2017.04.023","volume":"8","author":"P Douvaras","year":"2017","unstructured":"Douvaras, P. et al. Directed differentiation of human pluripotent stem cells to microglia. Stem Cell Rep. 8, 1516\u20131524 (2017).","journal-title":"Stem Cell Rep."},{"key":"8544_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/hmg\/ddx382","volume":"27","author":"P Mesci","year":"2018","unstructured":"Mesci, P. et al. Modeling neuro-immune interactions during Zika virus infection. Hum. Mol. Genet. 27, 41\u201352 (2018).","journal-title":"Hum. Mol. Genet."},{"key":"8544_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nn.3599","volume":"17","author":"O Butovsky","year":"2014","unstructured":"Butovsky, O. et al. Identification of a unique TGF-\u03b2\u2013dependent molecular and functional signature in microglia. Nat. Neurosci. 17, 131\u2013143 (2014).","journal-title":"Nat. Neurosci."},{"key":"8544_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","volume":"9","author":"L Parnetti","year":"2013","unstructured":"Parnetti, L. et al. Cerebrospinal fluid biomarkers in Parkinson disease. Nat. Rev. Neurol. 9, 131\u2013140 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"8544_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12640-009-9140-z","volume":"19","author":"W Zhang","year":"2011","unstructured":"Zhang, W. et al. Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson\u2019s disease. Neurotox. Res. 19, 63\u201372 (2011).","journal-title":"Neurotox. Res."},{"key":"8544_CR27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/mds.26563","volume":"31","author":"CH Williams-Gray","year":"2016","unstructured":"Williams-Gray, C. H. et al. Serum immune markers and disease progression in an incident Parkinson\u2019s disease cohort (ICICLE-PD). Mov. Disord. 31, 995\u20131003 (2016).","journal-title":"Mov. Disord."},{"key":"8544_CR28","doi-asserted-by":"publisher","unstructured":"Nagatsu, T., Mogi, M., Ichinose, H. & Togari, A. Changes in cytokines and neurotrophins in Parkinson\u2019s disease. J. Neural Transm. Suppl. 277\u2013290 https:\/\/doi.org\/10.1007\/978-3-7091-6301-6_19 (2000).","DOI":"10.1007\/978-3-7091-6301-6_19"},{"key":"8544_CR29","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s11064-009-9921-z","volume":"34","author":"KW Hofmann","year":"2009","unstructured":"Hofmann, K. W. et al. Interleukin-6 serum levels in patients with Parkinson\u2019s disease. Neurochem. Res. 34, 1401\u20131404 (2009).","journal-title":"Neurochem. Res."},{"key":"8544_CR30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jneuroim.2009.08.001","volume":"216","author":"P Scalzo","year":"2009","unstructured":"Scalzo, P., K\u00fcmmer, A., Cardoso, F. & Teixeira, A. L. Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson\u2019s disease. J. Neuroimmunol. 216, 122\u2013125 (2009).","journal-title":"J. Neuroimmunol."},{"key":"8544_CR31","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"X-Y Qin","year":"2016","unstructured":"Qin, X.-Y., Zhang, S.-P., Cao, C., Loh, Y. P. & Cheng, Y. Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 73, 1316\u20131324 (2016).","journal-title":"JAMA Neurol."},{"key":"8544_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.1227901","volume":"339","author":"A Aguzzi","year":"2013","unstructured":"Aguzzi, A., Barres, B. A. & Bennett, M. L. Microglia: scapegoat, saboteur, or something else?. Science 339, 156\u2013161 (2013).","journal-title":"Science"},{"key":"8544_CR33","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1126\/science.1202529","volume":"333","author":"RC Paolicelli","year":"2011","unstructured":"Paolicelli, R. C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456\u20131458 (2011).","journal-title":"Science"},{"key":"8544_CR34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-neuro-061010-113810","volume":"35","author":"AH Stephan","year":"2012","unstructured":"Stephan, A. H., Barres, B. A. & Stevens, B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci. 35, 369\u2013389 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"8544_CR35","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/mds.27776","volume":"34","author":"M Vila","year":"2019","unstructured":"Vila, M. Neuromelanin, aging, and neuronal vulnerability in Parkinson\u2019s disease. Mov. Disord. 34, 1440\u20131451 (2019).","journal-title":"Mov. Disord."},{"key":"8544_CR36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard, A. et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol. Dis. 21, 404\u2013412 (2006).","journal-title":"Neurobiol. Dis."},{"key":"8544_CR37","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1474-4422(17)30173-4","volume":"16","author":"MG Stokholm","year":"2017","unstructured":"Stokholm, M. G. et al. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurol. 16, 789\u2013796 (2017).","journal-title":"Lancet Neurol."},{"key":"8544_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.parkreldis.2009.05.005","volume":"16","author":"AL Bartels","year":"2010","unstructured":"Bartels, A. L. et al. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson\u2019s disease?. Parkinsonism Relat. Disord. 16, 57\u201359 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"8544_CR39","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1021\/acschemneuro.0c00336","volume":"11","author":"M Gonzalez-Sepulveda","year":"2020","unstructured":"Gonzalez-Sepulveda, M. et al. Validation of a reversed phase UPLC-MS\/MS method to determine dopamine metabolites and oxidation intermediates in neuronal differentiated SH-SY5Y cells and brain tissue. ACS Chem. Neurosci. 11, 2679\u20132687 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"8544_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.stemcr.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico, A. et al. Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease. Stem Cell Rep. 12, 213\u2013229 (2019).","journal-title":"Stem Cell Rep."},{"key":"8544_CR41","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s10753-023-01829-y","volume":"46","author":"Y Xie","year":"2023","unstructured":"Xie, Y., Jin, C., Sang, H., Liu, W. & Wang, J. Ivermectin protects against experimental autoimmune encephalomyelitis in mice by modulating the Th17\/Treg balance involved in the IL-2\/STAT5 pathway. Inflammation 46, 1626\u20131638 (2023).","journal-title":"Inflammation"},{"key":"8544_CR42","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708743","volume":"10","author":"A Zabala","year":"2018","unstructured":"Zabala, A. et al. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis. EMBO Mol. Med. 10, e8743 (2018).","journal-title":"EMBO Mol. Med."},{"key":"8544_CR43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481\u2013487 (2017).","journal-title":"Nature"},{"key":"8544_CR44","first-page":"1003","volume":"1","author":"D Kempuraj","year":"2016","unstructured":"Kempuraj, D. et al. Neuroinflammation induces neurodegeneration. J. Neurol. Neurosurg. Spine 1, 1003 (2016).","journal-title":"J. Neurol. Neurosurg. Spine"},{"key":"8544_CR45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth, H. D. E., Hirst, W. D. & Wade-Martins, R. The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends Neurosci. 40, 358\u2013370 (2017).","journal-title":"Trends Neurosci."},{"key":"8544_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00401-008-0361-7","volume":"116","author":"L Zecca","year":"2008","unstructured":"Zecca, L. et al. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson\u2019s disease. Acta Neuropathol. 116, 47\u201355 (2008).","journal-title":"Acta Neuropathol."},{"key":"8544_CR47","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1021\/acschemneuro.6b00231","volume":"8","author":"E Ferrari","year":"2017","unstructured":"Ferrari, E. et al. Synthesis, structure characterization, and evaluation in microglia cultures of neuromelanin analogues suitable for modeling Parkinson\u2019s disease. ACS Chem. Neurosci. 8, 501\u2013512 (2017).","journal-title":"ACS Chem. Neurosci."},{"key":"8544_CR48","doi-asserted-by":"publisher","first-page":"4176","DOI":"10.3390\/ijms23084176","volume":"23","author":"T Nagatsu","year":"2022","unstructured":"Nagatsu, T., Nakashima, A., Watanabe, H., Ito, S. & Wakamatsu, K. Neuromelanin in Parkinson\u2019s disease: tyrosine hydroxylase and tyrosinase. IJMS 23, 4176 (2022).","journal-title":"IJMS"},{"key":"8544_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53168-7","volume":"15","author":"A Laguna","year":"2024","unstructured":"Laguna, A. et al. Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits. Nat. Commun. 15, 8819 (2024).","journal-title":"Nat. Commun."},{"key":"8544_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/nature22403","volume":"546","author":"H Kilpinen","year":"2017","unstructured":"Kilpinen, H. et al. Common genetic variation drives molecular heterogeneity in human iPSCs. Nature 546, 370\u2013375 (2017).","journal-title":"Nature"},{"key":"8544_CR51","doi-asserted-by":"publisher","first-page":"dmm042317","DOI":"10.1242\/dmm.042317","volume":"13","author":"V Volpato","year":"2020","unstructured":"Volpato, V. & Webber, C. Addressing variability in iPSC-derived models of human disease: guidelines to promote reproducibility. Dis. Models Mech. 13, dmm042317 (2020).","journal-title":"Dis. Models Mech."},{"key":"8544_CR52","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","volume":"19","author":"O Butovsky","year":"2018","unstructured":"Butovsky, O. & Weiner, H. L. Microglial signatures and their role in health and disease. Nat. Rev. Neurosci. 19, 622\u2013635 (2018).","journal-title":"Nat. Rev. Neurosci."},{"key":"8544_CR53","doi-asserted-by":"publisher","first-page":"e0165949","DOI":"10.1371\/journal.pone.0165949","volume":"11","author":"A Speidel","year":"2016","unstructured":"Speidel, A., Felk, S., Reinhardt, P., Sterneckert, J. & Gillardon, F. Leucine-rich repeat kinase 2 influences fate decision of human monocytes differentiated from induced pluripotent stem cells. PLoS ONE 11, e0165949 (2016).","journal-title":"PLoS ONE"},{"key":"8544_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9255","volume":"6","author":"I Choi","year":"2015","unstructured":"Choi, I. et al. LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase. Nat. Commun. 6, 8255 (2015).","journal-title":"Nat. Commun."},{"key":"8544_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-49294-9","volume":"13","author":"S Ohtonen","year":"2023","unstructured":"Ohtonen, S. et al. Human iPSC-derived microglia carrying the LRRK2-G2019S mutation show a Parkinson\u2019s disease related transcriptional profile and function. Sci. Rep. 13, 22118 (2023).","journal-title":"Sci. Rep."},{"key":"8544_CR56","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.bbrc.2016.11.163","volume":"482","author":"DH Ho","year":"2017","unstructured":"Ho, D. H., Seol, W., Eun, J. H. & Son, I. Phosphorylation of p53 by LRRK2 induces microglial tumor necrosis factor \u03b1-mediated neurotoxicity. Biochem. Biophys. Res. Commun. 482, 1088\u20131094 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"8544_CR57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.5607\/en.2018.27.3.171","volume":"27","author":"DH Ho","year":"2018","unstructured":"Ho, D. H. et al. LRRK2 kinase activity induces mitochondrial fission in microglia via Drp1 and modulates neuroinflammation. Exp. Neurobiol. 27, 171\u2013180 (2018).","journal-title":"Exp. Neurobiol."},{"key":"8544_CR58","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1093\/brain\/awh625","volume":"128","author":"CF Orr","year":"2005","unstructured":"Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H. & Halliday, G. M. A possible role for humoral immunity in the pathogenesis of Parkinson\u2019s disease. Brain 128, 2665\u20132674 (2005).","journal-title":"Brain"},{"key":"8544_CR59","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00401-007-0250-5","volume":"114","author":"TG Beach","year":"2007","unstructured":"Beach, T. G. et al. Marked microglial reaction in normal aging human substantia nigra: correlation with extraneuronal neuromelanin pigment deposits. Acta Neuropathol. 114, 419\u2013424 (2007).","journal-title":"Acta Neuropathol."},{"key":"8544_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","volume":"70","author":"C Depboylu","year":"2011","unstructured":"Depboylu, C. et al. Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J. Neuropathol. Exp. Neurol. 70, 125\u2013132 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"8544_CR61","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/cells8070766","volume":"8","author":"D Walker","year":"2019","unstructured":"Walker, D., Lue, L.-F., Beach, T. & Tooyama, I. Microglial phenotyping in neurodegenerative disease brains: identification of reactive microglia with an antibody to variant of CD105\/endoglin. Cells 8, 766 (2019).","journal-title":"Cells"},{"key":"8544_CR62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.nbd.2006.08.018","volume":"25","author":"M Andries","year":"2007","unstructured":"Andries, M., Van Damme, P., Robberecht, W. & Van Den Bosch, L. Ivermectin inhibits AMPA receptor-mediated excitotoxicity in cultured motor neurons and extends the life span of a transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 25, 8\u201316 (2007).","journal-title":"Neurobiol. Dis."},{"key":"8544_CR63","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1007\/s11011-023-01290-8","volume":"38","author":"B Seyyedabadi","year":"2023","unstructured":"Seyyedabadi, B., Babataheri, S., Laher, I. & Soraya, H. Neuroprotective effects of ivermectin against transient cerebral ischemia-reperfusion in rats. Metab. Brain Dis. 38, 2807\u20132815 (2023).","journal-title":"Metab. Brain Dis."},{"key":"8544_CR64","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/emmm.201200215","volume":"4","author":"A S\u00e1nchez-Dan\u00e9s","year":"2012","unstructured":"S\u00e1nchez-Dan\u00e9s, A. et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson\u2019s disease. EMBO Mol. Med. 4, 380\u2013395 (2012).","journal-title":"EMBO Mol. Med."},{"key":"8544_CR65","doi-asserted-by":"publisher","first-page":"e59243","DOI":"10.1371\/journal.pone.0059243","volume":"8","author":"MD Yanagimachi","year":"2013","unstructured":"Yanagimachi, M. D. et al. Robust and highly-efficient differentiation of functional monocytic cells from human pluripotent stem cells under serum- and feeder cell-free conditions. PLoS ONE 8, e59243 (2013).","journal-title":"PLoS ONE"},{"key":"8544_CR66","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson\u2019s disease. Nature 480, 547\u2013551 (2011).","journal-title":"Nature"},{"key":"8544_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05633-1","volume":"7","author":"S Fedele","year":"2017","unstructured":"Fedele, S. et al. Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential. Sci. Rep. 7, 6036 (2017).","journal-title":"Sci. Rep."},{"key":"8544_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275\u2013280 (2009).","journal-title":"Nat. Biotechnol."},{"key":"8544_CR69","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/hum.2011.054","volume":"23","author":"A S\u00e1nchez-Dan\u00e9s","year":"2012","unstructured":"S\u00e1nchez-Dan\u00e9s, A. et al. Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells. Hum. Gene Ther. 23, 56\u201369 (2012).","journal-title":"Hum. Gene Ther."},{"key":"8544_CR70","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.stemcr.2017.05.017","volume":"8","author":"W Haenseler","year":"2017","unstructured":"Haenseler, W. et al. A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response. Stem Cell Rep. 8, 1727\u20131742 (2017).","journal-title":"Stem Cell Rep."},{"key":"8544_CR71","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/nmeth.3125","volume":"11","author":"TA Ferreira","year":"2014","unstructured":"Ferreira, T. A. et al. Neuronal morphometry directly from bitmap images. Nat. Methods 11, 982\u2013984 (2014).","journal-title":"Nat. Methods"},{"key":"8544_CR72","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202215847","volume":"15","author":"A Trist\u00e1n-Noguero","year":"2023","unstructured":"Trist\u00e1n-Noguero, A. et al. iPSC -based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation. EMBO Mol. Med. 15, e15847 (2023).","journal-title":"EMBO Mol. Med."},{"key":"8544_CR73","doi-asserted-by":"publisher","unstructured":"Byun, Y. G. & Chung, W.-S. A. Novel in vitro live-imaging assay of astrocyte-mediated phagocytosis using pH indicator-conjugated synaptosomes. J. Vis. Exp. 56647 https:\/\/doi.org\/10.3791\/56647 (2018).","DOI":"10.3791\/56647"},{"key":"8544_CR74","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/mp.2016.220","volume":"22","author":"CM Sellgren","year":"2017","unstructured":"Sellgren, C. M. et al. Patient-specific models of microglia-mediated engulfment of synapses and neural progenitors. Mol. Psychiatry 22, 170\u2013177 (2017).","journal-title":"Mol. Psychiatry"},{"key":"8544_CR75","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/pcmr.12121","volume":"26","author":"M d\u2019Ischia","year":"2013","unstructured":"d\u2019Ischia, M. et al. Melanins and melanogenesis: methods, standards, protocols. Pigment Cell Melanoma Res. 26, 616\u2013633 (2013).","journal-title":"Pigment Cell Melanoma Res."},{"key":"8544_CR76","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/ijms18030478","volume":"18","author":"J Pujols","year":"2017","unstructured":"Pujols, J., et al. High-throughput screening methodology to identify alpha-synuclein aggregation inhibitors. Int. J. Mol. Sci. 18, 478 (2017).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08544-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08544-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08544-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:35:20Z","timestamp":1757381720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08544-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8544"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08544-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.07.616997","asserted-by":"object"}]},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1203"}}